Forskning
Udskriv Udskriv
Switch language
  1. Rigshospitalet
  2. Publikationer
  3. Risk group assignment differs for childr...
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

DOI

Fra samme tidsskrift

  1. Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  2. Insulin-like growth factor 1 and insulin-like growth factor binding protein-3: impact on early haematopoietic reconstitution following allogeneic haematopoietic stem cell transplantation

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  3. Prevalence of non-adherence and non-compliance during maintenance therapy in adults with acute lymphoblastic leukemia and their associations with survival

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  4. High pre-harvest donor Foxp3 mRNA level predicts late relapse of acute lymphoblastic leukaemia after haematopoietic stem cell transplantation

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  5. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin Lymphoma and in Hodgkin Lymphoma survivors

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Med samme forfattere

  1. Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  2. Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  3. Doing less, accomplishing more for childhood ALL: response

    Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

  4. Remission, treatment failure, and relapse in pediatric ALL: An international consensus of the Ponte-di-Legno Consortium

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  5. A qualitative study of young childhood cancer survivors and their parents' experiences with treatment-related late effects in everyday life post-treatment

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Nina Toft
  • Henrik Birgens
  • Jonas Abrahamsson
  • Per Bernell
  • Laimonas Griškevičius
  • Helene Hallböök
  • Mats Heyman
  • Mette Skov Holm
  • Erik Hulegårdh
  • Tobias Wirenfeldt Klausen
  • Hanne V Marquart
  • Olafur Gísli Jónsson
  • Ove Juul Nielsen
  • Petter Quist-Paulsen
  • Mervi Taskinen
  • Goda Vaitkeviciene
  • Kim Vettenranta
  • Ann Åsberg
  • Kjeld Schmiegelow
Vis graf over relationer
The prognosis of acute lymphoblastic leukemia is poorer in adults than in children. Studies have indicated that young adults benefit from pediatric treatment, although no upper age limit has been defined.
OriginalsprogEngelsk
TidsskriftEuropean Journal of Haematology
Vol/bind90
Udgave nummer5
Sider (fra-til)404-12
Antal sider9
ISSN0902-4441
DOI
StatusUdgivet - maj 2013

ID: 38977684